Marksans Pharma Ltd. Conference Calls and Earnings Call Transcripts

Marksans Pharma Ltd. Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans, and more.

Quarter
All Apr-Jun 2026 Jan-Mar 2026 Oct-Dec 2025 Jul-Sep 2025 Apr-Jun 2025 Jan-Mar 2025 Oct-Dec 2024 Jul-Sep 2024 Apr-Jun 2024 Jan-Mar 2024 Oct-Dec 2023 Jul-Sep 2023 Apr-Jun 2023 Jan-Mar 2023 Oct-Dec 2022 Jul-Sep 2022 Apr-Jun 2022 Jan-Mar 2022 Oct-Dec 2021 Jul-Sep 2021 Apr-Jun 2021 Jan-Mar 2021 Oct-Dec 2020 Jul-Sep 2020 Apr-Jun 2020 Jan-Mar 2020 Oct-Dec 2019 Jul-Sep 2019 Apr-Jun 2019 Jan-Mar 2019 Oct-Dec 2018 Jul-Sep 2018 Apr-Jun 2018 Jan-Mar 2018 Oct-Dec 2017 Jul-Sep 2017 Apr-Jun 2017 Jan-Mar 2017 Oct-Dec 2016 Jul-Sep 2016 Apr-Jun 2016 Jan-Mar 2016 Oct-Dec 2015
announcement
Conference/Earnings Calls Alerts
logo
Marksans Pharma Ltd.
03 Jun 2026
256.07
-2.64%
pdf
logo
Marksans Pharma Ltd.
27 May 2026
256.07
-2.64%
Marksans Pharma Results Earnings Call for Q4FY26 & Full Year
Conference Call with Marksans Pharma Management and Analysts on Q4FY26 & Full Year Performance and Outlook. Listen to the full earnings transcript.
video
audio
 
logo
Marksans Pharma Ltd.
12 Feb 2026
256.07
-2.64%
pdf
logo
Marksans Pharma Ltd.
14 Nov 2025
256.07
-2.64%
Marksans Pharma Results Earnings Call for Q2FY26
Conference Call with Marksans Pharma Management and Analysts on Q2FY26 Performance and Outlook. Listen to the full earnings transcript.
video
audio
 
AI Summary
logo
Marksans Pharma Ltd.
19 Aug 2025
256.07
-2.64%
AI Summary
pdf
logo
Marksans Pharma Ltd.
13 Aug 2025
256.07
-2.64%
pdf
logo
Marksans Pharma Ltd.
20 May 2025
256.07
-2.64%
Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we hereby inform the stock exchanges that the Company has uploaded the audio recording of investor(s) / analyst(s) meet for Q4FY25 financial performance and strategy update held today i.e. May 20, 2025 on the Company's website at http://marksanspharma.com/investors-meet.html
pdf
logo
Marksans Pharma Ltd.
20 May 2025
256.07
-2.64%
Marksans Pharma Results Earnings Call for Q4FY25 & Full Year
Conference Call with Marksans Pharma Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.
video
audio
 
logo
Marksans Pharma Ltd.
25 Feb 2025, 12:08PM
256.07
-2.64%
pdf
AI Summary
logo
Marksans Pharma Ltd.
25 Feb 2025, 12:03PM
256.07
-2.64%
AI Summary
pdf

Earnings Calls Podcast on